Core Viewpoint - Rosen Law Firm is reminding investors who purchased Zynex, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Zynex securities between March 13, 2023, and March 11, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by May 19, 2025 [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3] Group 3: Allegations Against Zynex - The lawsuit alleges that Zynex failed to disclose that it shipped products in excess of need, which inflated its revenue [4] - It is claimed that Zynex's practice of filing false claims attracted scrutiny from insurers, leading to potential adverse consequences, including removal from insurer networks and federal penalties [4] - The lawsuit asserts that the positive statements made by Zynex regarding its business and operations were materially misleading [4]

Core Viewpoint - A class action lawsuit has been filed against West Pharmaceutical Services, Inc. for misleading statements regarding its business performance and product demand during the specified Class Period from February 16, 2023, to February 12, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that West Pharmaceutical made false and misleading statements about its visibility into customer demand and the impact of COVID-related product destocking, while in reality, it was experiencing significant destocking in its High-Value Products portfolio [5]. - It is alleged that West's SmartDose device, intended as a high-margin growth product, negatively impacted profit margins due to operational inefficiencies [5]. - The lawsuit also highlights that margin pressures could lead to costly restructuring activities, including the exit from continuous glucose monitoring contracts with long-standing customers [5]. - As a result of these issues, the positive statements made by the defendants regarding West's business and prospects were materially false or misleading [5]. Group 2: Participation Information - Investors who purchased West common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm for more information [3][6].

LOS ANGELES, May 8, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE: SLQT) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. SelectQuote is the subject of a DOJ False Claims Act filed on May 1, 2025. The f ...

NEW YORK, May 5, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ: BLZE) resulting from allegations that Backblaze may have issued materially misleading business information to the investing public.So What: If you purchased Backblaze securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The ...

PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors who purchased stock in Open Lending Corp. (NASDAQ: LPRO) between February 24, 2022 and March 31, 2025.  Open Lending is a provider of services to automotive lenders. WHAT’S THIS ABOUT?On March 17, 2025, Open Lending announced that it would postpone its earnings release and conference call, both scheduled for the same day. The company also filed a ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time and has consistently ranked highly in securities class action settlements [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Teleflex Incorporated due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by a significant drop in Teleflex's stock price, which fell by 21.6% on February 27, 2025, following the announcement of a company split and a €760 million deal with Biotronik [3]. - Shareholders who purchased Teleflex securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering hundreds of millions for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, achieving the largest settlement against a Chinese company at the time and ranking highly in the number of settlements since 2013 [4].

SAN DIEGO, May 1, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Fluence Energy, Inc. (NASDAQ: FLNC) Class A common stock between October 28, 2021 and February 10, 2025, inclusive (the "Class Period"), have until May 12, 2025 to seek appointment as lead plaintiff of the Fluence Energy class action lawsuit. Captioned Kramer v. Fluence Energy, Inc., No. 25-cv-00634 (E.D. Va.), the Fluence Energy class action lawsuit charges Fluence Energy as well as certain of Fluence Energ ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased BigBear.ai Holdings, Inc. securities between March 31, 2022, and March 25, 2025, of the June 10, 2025, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased BigBear.ai securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court by June 10, 2025, to serve as lead plaintiff, representing other class members [3]. - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that BigBear.ai made false and misleading statements and failed to disclose deficiencies in accounting review policies related to certain complex transactions [5]. - Specific allegations include improper accounting for the 2026 Convertible Notes and the likelihood of needing to restate previously issued financial statements due to inaccuracies [5]. - The lawsuit claims that these misstatements led to investor damages when the true details became public [5].

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Napco Security Technologies, Inc. (NASDAQ: NSSC) securities between February 5, 2024 and February 3, 2025. Napco develops, manufactures, and sells high-tech electronic security devices and provides cellular communication services for intrusion and fire alarm systems. For more information, submit a form, email attorney Aaron Dumas, Jr., or ...